PMID: 11901034Mar 20, 2002Paper

Successful treatment of amiodarone-induced thyrotoxicosis

Circulation
Faizel OsmanMichael D Gammage

Abstract

Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem about which there are little published data. We examined whether continuing amiodarone or differentiating AIT into 2 subtypes affected outcome. The type and duration of antithyroid treatment and response were recorded in a consecutive series of 28 cases. Comparisons were made between those in whom amiodarone either was continued or stopped and between those with either possible type 1 or type 2 AIT. Of the 28 cases, 5 had spontaneous resolution of AIT; 23 received carbimazole (CBZ) alone as first-line therapy. Eleven achieved long-term euthyroidism off CBZ or on a maintenance dose. Five became hypothyroid and required long-term thyroxine. Five relapsed after stopping CBZ treatment and were rendered euthyroid with either long-term CBZ (n=3) or radioiodine (n=2). Four were intolerant of CBZ and received propylthiouracil (PTU), with good effect in 3. One was resistant to thionamide alone (CBZ then PTU) and responded to adjunctive steroids. No difference in presentation or outcome was noted between those in whom amiodarone was continued or stopped or between possible type 1 or type 2 AIT. Continuing amiodarone has no adverse influence on response to treatment...Continue Reading

Citations

Jun 5, 2003·European Journal of Pharmacology·Shinobu MatsuiMichael L X Fu
Sep 7, 2006·Postgraduate Medical Journal·L D K E Premawardhana, J H Lazarus
Jun 1, 2011·Therapeutic Advances in Endocrinology and Metabolism·Shashithej K NarayanaChristopher J Boos
Nov 15, 2007·Journal of Medical Case Reports·Vasilios PapaioannouIoannis Pneumatikos
Mar 8, 2012·Lancet·Jayne A Franklyn, Kristien Boelaert
May 4, 2011·Clinical Endocrinology·Sheba AhmedThera P Links
Jun 14, 2003·Otolaryngologic Clinics of North America·Joseph C Sniezek, Thomas B Francis
Jul 2, 2005·The American Journal of Medicine·Shehzad Basaria, David S Cooper
Aug 30, 2008·Clinical Endocrinology·T S HanM P J Vanderpump
Dec 18, 2013·Orvosi hetilap·Gergely LakatosKároly Rácz
Jun 19, 2007·Journal of the American College of Cardiology·David ConenStefan Osswald
Mar 4, 2011·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Nieves AriasAntonio M Picó

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.